Drug Type Small molecule drug |
Synonyms triterpenoids (Dartmouth), RTA-404 |
Target |
Action antagonists |
Mechanism Cytokine receptors antagonists |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingDiscovery |
First Approval Date- |
Regulation- |
Molecular FormulaC33H43F3N2O3 |
InChIKeyUBRASLQCAYTTEB-KPOXMGGZSA-N |
CAS Registry932730-52-4 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Alzheimer Disease | Discovery | United States | - | |
Brain Cancer | Discovery | United States | - | |
Multiple Sclerosis | Discovery | United States | - | |
Parkinson Disease | Discovery | United States | - |
Study | Phase | Population | Analyzed Enrollment | Group | Results | Evaluation | Publication Date |
---|
No Data |